Relationship between the Size and Location of the Mass and Hilar and Mediastinal Lymph Node Metastasis in Early and Locally Advanced Non-small Cell Lung Cancer
, 2020
Efficacy of regorafenib in the second-and third-line settingfor patients with advanced hepatocellular carcinoma: A reallife data of multicenter study from Turkey
, 2020
Skeletal muscle loss during anti-epidermal growth factor receptor therapy is an independent prognostic factor on non-small cell lung cancer patients survival.
, 2021
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
, 2020
BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
, 2023
PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score
, 2023
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series
, 2022
Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non‐small cell lung cancer: A randomized, double‐blind, phase III study
, 2023
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
, 2020
Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
, 2020
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study
, 2023
Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102
, 2019
Classifying Invasive Lobular Carcinoma as Special Type Breast Cancer May Be Reducing Its Treatment Success: A comparison of Survival Among Invasive Lobular Carcinoma, Invasive Ductal Carcinoma, and No-Lobular Special Type Breast Cancer
, 2023
The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study
, 2022
Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib
, 2022
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
, 2020
Regorafenib or rechallenge chemotherapy: Which is more effective in the third-line treatment of metastatic colorectal cancer?
, 2019
Efficacy of Regorafenib in the Second-and Third-line Settingfor Patients with Advanced Hepatocellular Carcinoma: A RealLife Data of Multicenter Study from Turkey
, 2020
External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database
, 2023
Concordance of PD-L1 expression and CD8+ TIL intensity between NSCLC and synchronous brain metastases
, 2019
Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?
, 2019
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
, 2019
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade
, 2022
Prognostic Factors for Survival in Transverse Colon Cancers
, 2022
ALK TKI therapy in patients with ALK-positive non-small cell lung cancer and brain metastases: A review of the literature and local experiences
, 2022
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey
, 2022
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)
, 2022
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
, 2022
An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
, 2022
Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide
, 2022
Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series
, 2022
Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcoma
, 2022
Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma
, 2022
Prognostic nutritional index and its dynamics after curative treatment are independent prognostic factors on survival in non-metastatic nasopharyngeal carcinoma
, 2022
GLASS: Global Lorlatinib for ALK() and ROS1() retrospective Study: real world data of 123 NSCLC patients
, 2020
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies
, 2022
An experimental study: the effect of S. boulardii on abemaciclib-induced diarrhea
, 2023
Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak
, 2020
Colonic Metastasis from Carcinoma of the Breast that Mimics a Primary Intestinal Cancer
, 2006
Investigation of The Relationship of <i>TNFRSF11A</i> Gene Polymorphisms with Breast Cancer Development and Metastasis Risk in Patients with <i>BRCA1</i> Or <i>BRCA2</i> Pathogenic Variants Living in The Trakya Region of Turkey.
, 2021
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study
, 2021
Stage I colon cancer that spreads into a colovesical fistula-mediated bladder due to crohn’s disease: A case report
, 2020
Prognostic Effect of Albumin-Bilirubin Grade on Survival in Advance Gastric Cancer Patients with de-novo Liver Metastasis
, 2020
Comparison of Neoadjuvant Chemotherapy and Bladder-Preserving Chemoradiation in Patients with Non-Metastatic, Muscle-Invasive Bladder Cancer: A Single-Center Experience
, 2020
Merkel cell carcinoma in Turkey: A multicentric study
, 2021
Secondary pneumothorax during immunotherapy in two patients with metastatic solid tumors; a new entity
, 2021
Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?
, 2021
Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study
, 2020
Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study
, 2020
Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey
, 2020
Genetic screening results of individuals with high risk BRCArelated breast/ovarian cancer in Trakya region of Turkey
, 2020
Investigation of the relationship between GSTM1 gene variations and serum trace elements, plasma malondialdehyde levels in patients with colorectal cancer.
, 2021
Clinicopathological and prognostic characteristics of acral metastases in patients with malignant disease: A retrospective study
, 2021
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non\u2013Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study
, 2021
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study
, 2021
Comparison of skeletal muscle mass loss in patients withmetastatic colorectal cancer treated with regorafenib orTAS-102
, 2019
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
, 2021
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
, 2021
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non\u2013Small Cell Lung Cancer
, 2021
Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective
, 2021
The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas
, 2020
Real-life data on first-line Sunitinib and Pazopanib therapy in metastatic renal cell carcinoma patients: a single center experience
, 2021
The relation between tissue galectin-3 level and platinum resistance in neoadjuvant bladder cancer treatment
, 2021
Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma
, 2018
Need for Patient Education and Better Physician-Patient Communication in Melanoma Patients
, 2021
Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes
, 2018
GLASS: Global Lorlatinib for ALK() and ROS1() retrospective Study: real world data of 123 NSCLC patients
, 2020
Evaluating Sun Protection Behaviors and Skin Self Examination Practices Among the Family Members of Melanoma Patients in Turkey: A Cross-sectional Survey Study
, 2020
Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib
, 2019
Relationship between the Size and Location of the Mass and Hilar and Mediastinal Lymph Node Metastasis in Early and Locally Advanced Non-small Cell Lung Cancer
, 2020
Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study
, 2020
Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)
, 2018
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
, 2020
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study
, 2020
Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib
, 2019
GLASS: Global Lorlatinib for ALK() and ROS1() retrospective Study: real world data of 123 NSCLC patients
, 2020
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407
, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study
, 2020
Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinoma
, 2018
Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis
, 2020
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors
, 2014
Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey
, 2020
Incidence of contrast induced nephropathy in hospitalised patients with cancer
, 2014
Concordance of PD-L1 expression and CD8 TIL intensity between NSCLC and synchronous brain metastases
, 2020
The relationship between FDG PET/CT-defined metabolic parameters and the histopathological subtype of oesophageal carcinomas
, 2020
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
, 2019
Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study
, 2020
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer
, 2020
KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer
, 2016
Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second-line treatment
, 2016
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)
, 2019
Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer
, 2019
Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases
, 2019
The albumin-bilirubin (ALBI) grade as a significant prognostic factor in colorectal cancer patients with liver metastases
, 2019
Endometrial carcinoma and paraneoplastic immune thrombocytopenia
, 2016
Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma: Case report
, 2016
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
, 2018
Fatal hepatic veno-occlusive disease in an adult patient with Wilms’xx tumour.
, 2003
Effect of maximum tolerated doses and low dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin 1 levels in patients with advanced nonsmall cell lung cancer
, 2008
Performance Status is an Important Prognostic Factor in Second Line Treatment of Pancreaticobiliary Adenocarcinoma
, 2013
Clinical Features of the Patient with Multiple Primary Tumors: Single Center Experience
, 2017
K-RAS and N-RAS mutations in testicular germ cell tumors
, 2017
Targeted therapy with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer even with brain metastasis.
, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
, 2017
K-RAS and N-RAS mutations in testicular germ cell tumors
, 2017
Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma Case report
Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor EGFR mutation
, 2016
Endometrial carcinoma and paraneoplastic immune thrombocytopenia
, 2016
Post progression survival analysis of metastatic gastric and gastroesophageal junction cancer patients after second line treatment
, 2016
